Innovative Clinical Studies

Iris Pharma is a Clinical Research Organization (CRO) that offers a wide range of Clinical Studies for ocular drug development. We propose marketing surveys, but also manage the Clinical Studies and the clinical research of investigational medicinal product in ophthalmology services (phase I, phase II, phase III and phase IV, ocular pharmacokinetics).

We conduct Clinical Studies integrating your specific requirements with its own expertise. Our priority is to give a reliable solution to all situations with the highest reactivity.

New technologies for Clinical Studies

For over a decade, our Clinical Research Organization has been implicated in Clinical Studies:

Strategic clinical studies planning
Study Drug development consulting
Clinical studies feasibility and design
Support to investigators for non-commercial trials.

Clinical Studies to ensure your success

Our Contract Research Organization has the expertise in Clinical Studies, the innovative solutions and it makes use of new technologies to ensure your success:

Clinical studies in ophthalmology
Selection of coordinating investigators and other investigators
Site coordination
Management of biological samples
Management of investigational medicinal products
Clinical monitoring according to GCP/ICH guidelines
Investigators´ meetings and newsletters.

Clinical Studies expertise

Our Contract Research Organization offers Clinical Studies for :

Age-related Macular Degeneration (AMD or ARMD), Ocular device, Ocular Drug Development, Glaucoma, OHT (ocular hypertension), Dry eye syndrome, Contactology, Ocular Inflammation, Cataract, Surgery.